Blog

Receive instant notifications when news about your stocks is posted. Request your 1-week free trial at StreetInsider Premium here.

• Adds complementary training services to provide holistic customer support

• Deepens the experience with a high quality medical device advisory team

• Tracks the acquisitions of DataRevive and IDEC in 2019 and 2020

SAN FRANCISCO – (BUSINESS WIRE) – Validant, a leading transatlantic quality, compliance and regulation advisory group, has acquired Oriel STAT A MATRIX (‘Oriel’), a global medical device industry consulting and training company.

Oriel is headquartered in New Jersey and provides regulatory, quality, compliance advice and training to the medical device industry. Oriel is an industry leader in quality, compliance and auditor training for the medical device industry. It has the largest content library in the market and has relationships with 90% of the top ten medical device companies in the world. The company uses a combination of face-to-face and virtual training courses to ensure customers have access to knowledge offered by industry-leading instructors anytime, anywhere.

Validant’s acquisition of Oriel is another important step in its international growth strategy, which aims to combine world-class regulatory and quality providers and continue their aggressive growth with further investments. This is followed by the acquisition of DataRevive in 2019, a regulatory strategy and advice for global clients, and IDEC in 2020, a regulatory advice based in Tokyo.

The acquisition will expand the Validant Group’s offering to include training services and deepen regulatory advice through the integration of an experienced team. The combination also gives customers better access to industry-leading advisors and solutions across the product lifecycle.

Brian Burns, President of Validant, commented on the announcement: “It is a pleasure to announce the acquisition of Oriel STAT A MATRIX. Under the leadership of Alan Marash and Judith Glaser Marash, Oriel has grown into a leading training provider for medical device customers. We are excited to add this high quality team and complementary training services to the Validant Group’s combined offering as we cement our position as the world’s leading consultancy on quality, compliance and regulation in the life science sector. ”

Alan Marash, Oriel CEO, said, “With complementary services and shared experience in the medical device industry, we are excited to partner with Validant on the next stage of Oriel’s growth journey. I look forward to working with Chad Hedlund, who has been promoted to President of Oriel STAT A MATRIX, and the Validant team to improve the support we offer our clients on the full range of regulatory, compliance and Provide training services as well as the potential to expand our geographic presence into new markets. ”

Fairmount Partners provided investment banking and advisory services, Bailey & Glasser legal advice and Bruce Gendelman Insurance insurance advice to Oriel STAT A MATRIX shareholders.

OMM provided legal advice, RSM Global financial and accounting advice, Deloitte tax advice and Atlantic Global Risk Corporation insurance advice for Validant.

– ENDS –

Validation information

Validant is a leading international consulting firm for quality, compliance and regulation that combines industry expertise with innovation to develop tailor-made solutions for companies on the border to health. With many years of experience in and alongside the FDA and other regulatory agencies, we know how to cope with the complexity of today’s healthcare industry. More information is available at www.validant.com

About Oriel STAT A MATRIX

Oriel STAT A MATRIX was founded in 1968 and is headquartered in Union, New Jersey. The company is a global provider of consulting and training solutions for medical devices, IVD and combination products. Our goal is to help life science organizations interpret, understand and apply regulations by transferring knowledge and skills so that our customers can bring high quality medical products to market faster, and ultimately patient outcomes and quality of life can improve. More information is available at www.orielstat.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005038/de/

Instinctive partner

Agnes Stephens – [email protected]

Ross Gillam – [email protected]

Nick Corrin – [email protected]

Source: validation